|
RGC Regencell Bioscience Holdings Ltd 1829667 |
| Income Statement |
|
Net Income
|
2025-06-30
|
$-3,584,213.00 |
| Balance Sheet |
|
Current Assets
|
$4,902,813.00 |
|
Assets
|
$5,755,582.00 |
|
Current Liabilities
|
$663,673.00 |
|
Liabilities
|
$895,308.00 |
|
Equity
|
$4,860,274.00 |
|
Shares Out
|
494488908.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-3,113,576.00 |
|
Investing Cash Flow
|
$2,686,216.00 |
| Market Analysis |
Market Cap
|
$2,937,264,113.52 |
|
Price
|
$6.08 |
|
BVPS
|
0.01 |
|
PB
|
594.00 |
|
EPS
|
-0.72 |
|
FCF
|
$-3,266,265.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:17 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:11 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view RGC documents filed with the SEC.
RGC Filings
Clear
